LTGO · Latigo Biotherapeutics, Inc.
$23.04
+0.56 (+2.49%)
At close · Sep 4
Going-concern doubt
— cleared Sep 3, 2026
The latest filing states the doubt was alleviated.
“Accordingly, the prior substantial doubt about the Company's ability to continue as a going concern has been alleviated.”View the 10-Q filed Sep 3, 2026
Market Cap
$1.53B
Shares
66.30M
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
No Holdings Data
No institutional holdings data is available for this listed security yet.